Table 4.
Disease | MAF cases |
MAF controls |
MF02 | MF01 | MFcomb Fisher | MFcomb Stouffer |
---|---|---|---|---|---|---|
Amyotrophic Lateral Sclerosis (Finland) | 0.3449 | 0.3640 | 0.642 | 0.541 | 0.819 | 0.539 |
Amyotrophic Lateral Sclerosis (Irish) | 0.2943 | 0.2743 | 0.501 | 0.596 | 0.781 | 0.579 |
Celiac disease | 0.2723 | 0.2902 | 0.793 | 0.580 | 0.598 | 0.559 |
Multiple Sclerosis | 0.2491 | 0.2681 | 0.140 | 0.191 | 0.303 | 0.206 |
Multiple Sclerosis (WT2) | 0.2812 | 0.2712 | 0.084 | 0.034 | 0.090 | 0.030 |
Vitiligo (GWAS1) | 0.2593 | 0.3075 | 0.013 | 0.018 | 0.040 | 0.016 |
Vitiligo (GWAS2) | 0.2362 | 0.2787 | 0.044 | 0.023 | 0.071 | 0.051 |
Chron's disease (NIDDK) | 0.2929 | 0.2679 | 0.658 | 0.438 | 0.470 | 0.417 |
Chron's disease (WT) | 0.2684 | 0.2546 | 0.439 | 0.485 | 0.729 | 0.498 |
Psoriasis | 0.2536 | 0.2846 | 0.027 | 0.039 | 0.077 | 0.038 |
Type-2 Diabetes (GENEVA) | 0.2815 | 0.2733 | 0.503 | 0.375 | 0.671 | 0.381 |
Type-2 Diabetes (WT) | 0.2843 | 0.2689 | 0.202 | 0.389 | 0.346 | 0.425 |
Type-1 Diabetes | 0.2663 | 0.2674 | 0.255 | 0.390 | 0.466 | 0.445 |
Rheumatoid Arthritis | 0.2581 | 0.2676 | 0.374 | 0.626 | 0.444 | 0.633 |
Ankylosing Spondylitis | 0.2692 | 0.2706 | 0.211 | 0.685 | 0.024 | 0.625 |
Ulcerative Colitis | 0.2751 | 0.2705 | 0.548 | 0.769 | 0.564 | 0.797 |